February 09, 2018

BELLUS Health in a Volatile Market

Watching the markets fluctuate over the last few days, I am very grateful that we completed a $20M financing in December that:

  • increased our cash runway to two+ years and through multiple important business milestones;
  • included a wide spectrum of investors which diversifies our shareholder base
  • involved significant participation from validating investors, including insiders and sophisticated healthcare funds
  • as an equity-only financing allowed us to maintain a clean capital structure

The raise not only provides financial stability, but also a strong shareholder base and capital structure to grow from. While it’s still to be seen whether markets will remain volatile and if the flow of risk capital - including biotech financing - will be affected, BELLUS is well-financed and prepared to handle a rocky market, if needed.

December Financing by the Numbers

December Financing by the Numbers

Published by Roberto Bellini on February 9, 2018

Share this

Sign up for email alerts

Email Address *
Enter the code shown above.